Effects of fixation on RNA integrity in a liquid-based cervical cytology setting

Journal of Clinical Pathology

Volumn 61, Issue 1, 2008, Pages 132-137

  Horvath, Caroline ^a   Boulet, G ^a   Sahebali, S ^a   Bogers, J ^a,b   Depuydt, C ^b   Vereecken, A ^b   Vermeulen, T ^a   Vanden Broeck, D ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Laboratory for Clinical Pathology and Molecular Biology (Labo Lokeren Campus Riatol)   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA DEGRADATION; RNA ISOLATION; UTERINE CERVIX CYTOLOGY; HELA CELL; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; TISSUE FIXATION; UTERINE CERVIX TUMOR; VAGINA SMEAR;

FEMALE; HELA CELLS; HUMANS; MASS SCREENING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TISSUE FIXATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 38449089039     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.047266     Document Type: Article

References (25)

1. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003;9:348-59.
2. IARC Working Group, on the Evaluation of Cancer Prevention Strategies. Cervix cancer screening, volume 10. IARC Press, Lyon, 2005.
3. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
4. Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
5. Michalas SP. The Pap test: George N Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol 2000;90:135-8.
6. Stanley MA. Prognostic factors and new therapeutic approaches to cervical cancer. Virus Res 2002;89:241-8.
7. Baldwin P, Laskey R, Coleman N. Translational approaches to improving cervical screening. Nat Rev Cancer 2003;3:217-26.
8. Payne N, Chilcott J, McGoogan E. Liquid-based cytology for cervical screening. Cytopathology 2000;11:469-70.
9. Trempat P, Zenou RC, Brousset P. The assessment of DNA and RNA preservation in liquid-based cytology media. Mol Pathol 2002;55:125.
10. Cuschieri KS, Whitley MJ, Cubie HA. Human papillomavirus type specific DNA and RNA persistence - implications for cervical disease progression and monitoring. J Med Virol 2004;73:65-70.
11. Cuschieri KS, Beattie G, Hassan S, et al. Assessment of human papillomovirus mRNA detection over time in cervical specimens collected in liquid-based cytology medium. J Virol Methods 2005;124:211-5.
12. Dimulescu II, Unger ER, Lee DR, et al. Characterization of RNA in cytologic samples preserved in a methanol-based collection solution. Mol Diagn 1998;3:67-71.
13. Tarkowski TA, Rajeevan MS, Lee DR, et al. Improved detection of viral RNA isolated from liquid-based cytology samples. Mol Diagn 2001;6:125-30.
14. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93.
15. Habis AH, Vernon SD, Lee DR, et al. Molecular quality of exfoliated cervical cells: Implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev 2004;13:492-6.
16. Wang-Johanning F, Lu DW, Wang Y, et al. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from Thinprep Papanicolaou test using real-time polymerase chain reaction analysis. Cancer 2002;94:2199-210.
17. Depuydt CE, Vereecken AJ, Salembier GM, et al. Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer 2003;88:560-6.
18. Powell N, Smith K, Fiander A. Recovery of human papillomavirus nucleic acids from liquid-based cytology media. J Virol Methods 2006;137:58-62.
19. Kuhn L, Denny L, Pollack A, et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818-25.
20. Molden T, Kraus I, Karlsen F, et al. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 2005;14:367-72.
21. Molden T, Kraus I, Karlsen F, et al. Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age. Gynecol Oncol 2006;100:95-100.
22. Lie AK, Risberg B, Borge B, et al. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol 2005;97:908-15.
23. Nakagawa S, Yoshikawa H, Yasugi T, et al. Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type. J Med Virol 2000;62:251-8.
24. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 2006;27:126-39.
25. Antonov J, Goldstein DR, Oberli A, et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 2005;85:1040-50.